PE20040722A1 - Formas cristalinas del acido 3-metiltiofen-2-carboxilico - Google Patents
Formas cristalinas del acido 3-metiltiofen-2-carboxilicoInfo
- Publication number
- PE20040722A1 PE20040722A1 PE2003000741A PE2003000741A PE20040722A1 PE 20040722 A1 PE20040722 A1 PE 20040722A1 PE 2003000741 A PE2003000741 A PE 2003000741A PE 2003000741 A PE2003000741 A PE 2003000741A PE 20040722 A1 PE20040722 A1 PE 20040722A1
- Authority
- PE
- Peru
- Prior art keywords
- methylthiophen
- crystalline forms
- carboxyl acid
- refers
- same
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 230000004927 fusion Effects 0.000 abstract 2
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0217504.0A GB0217504D0 (en) | 2002-07-29 | 2002-07-29 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040722A1 true PE20040722A1 (es) | 2004-11-29 |
Family
ID=9941275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000741A PE20040722A1 (es) | 2002-07-29 | 2003-07-25 | Formas cristalinas del acido 3-metiltiofen-2-carboxilico |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7683048B2 (https=) |
| EP (2) | EP1554303B1 (https=) |
| JP (1) | JP2006501207A (https=) |
| KR (1) | KR100688371B1 (https=) |
| CN (1) | CN1305892C (https=) |
| AR (1) | AR040692A1 (https=) |
| AT (1) | ATE349459T1 (https=) |
| AU (1) | AU2003251651B2 (https=) |
| BR (1) | BR0313044A (https=) |
| CA (1) | CA2493330C (https=) |
| CY (1) | CY1106406T1 (https=) |
| DE (1) | DE60310747T2 (https=) |
| DK (1) | DK1554303T3 (https=) |
| EC (1) | ECSP055579A (https=) |
| ES (1) | ES2279970T3 (https=) |
| GB (1) | GB0217504D0 (https=) |
| HK (1) | HK1080484B (https=) |
| IL (2) | IL166287A0 (https=) |
| MX (1) | MXPA05001173A (https=) |
| MY (1) | MY136407A (https=) |
| NO (1) | NO20050806L (https=) |
| NZ (2) | NZ537868A (https=) |
| PE (1) | PE20040722A1 (https=) |
| PL (1) | PL209409B1 (https=) |
| PT (1) | PT1554303E (https=) |
| RU (2) | RU2330043C2 (https=) |
| SI (1) | SI1554303T1 (https=) |
| TW (1) | TWI309164B (https=) |
| WO (1) | WO2004013156A1 (https=) |
| ZA (1) | ZA200500370B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| SI1775305T1 (sl) | 2000-08-05 | 2015-01-30 | Glaxo Group Limited | S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo |
| KR100831534B1 (ko) | 2001-04-30 | 2008-05-22 | 글락소 그룹 리미티드 | 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체 |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| GB0523656D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523654D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0603783D0 (en) * | 2006-02-24 | 2006-04-05 | Novartis Ag | Organic compounds |
| RU2487131C2 (ru) * | 2008-03-14 | 2013-07-10 | Оцука Фармасьютикал Ко., Лтд. | Ингибитор ммр-2 и/или ммр-9 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU550939A1 (ru) * | 1975-05-19 | 1994-07-15 | Институт химии древесины АН ЛатвССР | 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли |
| JPH08291073A (ja) * | 1995-04-22 | 1996-11-05 | Kissei Pharmaceut Co Ltd | 医薬品組成物及びその製造方法 |
| GB0015876D0 (en) * | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
-
2002
- 2002-07-29 GB GBGB0217504.0A patent/GB0217504D0/en not_active Ceased
-
2003
- 2003-07-25 AR AR20030102680A patent/AR040692A1/es unknown
- 2003-07-25 PE PE2003000741A patent/PE20040722A1/es not_active Application Discontinuation
- 2003-07-28 AU AU2003251651A patent/AU2003251651B2/en not_active Ceased
- 2003-07-28 DK DK03766325T patent/DK1554303T3/da active
- 2003-07-28 MX MXPA05001173A patent/MXPA05001173A/es active IP Right Grant
- 2003-07-28 EP EP03766325A patent/EP1554303B1/en not_active Expired - Lifetime
- 2003-07-28 JP JP2004525343A patent/JP2006501207A/ja active Pending
- 2003-07-28 EP EP06005390A patent/EP1676854A1/en not_active Withdrawn
- 2003-07-28 US US10/522,358 patent/US7683048B2/en not_active Expired - Fee Related
- 2003-07-28 AT AT03766325T patent/ATE349459T1/de active
- 2003-07-28 NZ NZ537868A patent/NZ537868A/en unknown
- 2003-07-28 ES ES03766325T patent/ES2279970T3/es not_active Expired - Lifetime
- 2003-07-28 RU RU2005105688/04A patent/RU2330043C2/ru not_active IP Right Cessation
- 2003-07-28 HK HK06100247.5A patent/HK1080484B/en not_active IP Right Cessation
- 2003-07-28 RU RU2007143025/04A patent/RU2348646C1/ru not_active IP Right Cessation
- 2003-07-28 DE DE60310747T patent/DE60310747T2/de not_active Expired - Lifetime
- 2003-07-28 PT PT03766325T patent/PT1554303E/pt unknown
- 2003-07-28 KR KR1020057001581A patent/KR100688371B1/ko not_active Expired - Fee Related
- 2003-07-28 MY MYPI20032832A patent/MY136407A/en unknown
- 2003-07-28 TW TW092120513A patent/TWI309164B/zh not_active IP Right Cessation
- 2003-07-28 SI SI200330721T patent/SI1554303T1/sl unknown
- 2003-07-28 CN CNB038180596A patent/CN1305892C/zh not_active Expired - Fee Related
- 2003-07-28 CA CA2493330A patent/CA2493330C/en not_active Expired - Fee Related
- 2003-07-28 WO PCT/EP2003/008314 patent/WO2004013156A1/en not_active Ceased
- 2003-07-28 PL PL373140A patent/PL209409B1/pl not_active IP Right Cessation
- 2003-07-28 NZ NZ549713A patent/NZ549713A/en unknown
- 2003-07-28 BR BR0313044-4A patent/BR0313044A/pt not_active IP Right Cessation
-
2005
- 2005-01-13 IL IL16628705A patent/IL166287A0/xx unknown
- 2005-01-14 ZA ZA200500370A patent/ZA200500370B/en unknown
- 2005-01-26 EC EC2005005579A patent/ECSP055579A/es unknown
- 2005-02-15 NO NO20050806A patent/NO20050806L/no unknown
-
2007
- 2007-03-22 CY CY20071100400T patent/CY1106406T1/el unknown
- 2007-07-26 IL IL184848A patent/IL184848A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040722A1 (es) | Formas cristalinas del acido 3-metiltiofen-2-carboxilico | |
| IT8619004A0 (it) | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. | |
| CA2274074A1 (en) | Novel compounds with analgesic effect | |
| AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
| PE20020529A1 (es) | Forma de dosificacion farmaceutica con multiples recubrimientos para reducir el impacto de fracturas del recubrimiento | |
| EE200100010A (et) | Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis | |
| ATE64297T1 (de) | Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung. | |
| AU2003239609A1 (en) | 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same | |
| AU2003215245A1 (en) | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof | |
| EE200100007A (et) | Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis | |
| IT8848730A0 (it) | Derivati 17beta-oh 19-nor steroidei sostituiti in 17alfa, procedimento di preparazione, loro impiego come medicamenti e composizioni farmaceutiche che li compongono | |
| EE200100559A (et) | Atsetüülsalitsüülhapet ja klopidogreelvesiniksulfaati sisaldav farmatseutiline kompositsioon üksikannusvormis | |
| AU2003271510A1 (en) | Formulation of oral compositions comprising arsenic trioxide and methods of use thereof | |
| DE60022188D1 (de) | Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen | |
| AU2003243719A1 (en) | Topical administration of pharmacologically active bases in the treatment of warts | |
| CA2396111A1 (en) | Substances for use in treating psoriasis | |
| ATE534636T1 (de) | Krystalline form ii von ritonavir enthaltende pharmazeutische zusammensetzung und ihre herstellung | |
| EE200200057A (et) | Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon | |
| IL167250A (en) | Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases | |
| AR033331A1 (es) | Formas polimorfas de un citrato de azabiciclo [2,2,2] octan-3-amina, sus composiciones farmaceuticas, procedimiento de tratamiento y procedimiento para su produccion. | |
| ATE290543T1 (de) | Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung | |
| AR015190A1 (es) | Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento | |
| DK1590317T3 (da) | Enantiomerren (4S,8S)- og (4R,8R)-4-p-nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecandisyre og dennes derivater, fremgangsmåde til disses fremstilling og anvendelse til fremstilling af farmaceutiske midler | |
| NO992668L (no) | Topisk preparat for innf°ring av farmas°ytisk aktive peptidforbindelser i levende organismer | |
| IT1245371B (it) | Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |